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Background: Severe falciparum malaria anaemia (SMA) is a frequent cause of mortality in children and pregnant
women. The most important determinant of SMA appears to be the loss of non-parasitized red blood cells
(np-RBCs) in excess of loss of parasitized (p-) RBCs at schizogony. Based on data from acute SMA where excretion of
haemoglobin in urine and increased plasma haemoglobin represented respectively less than 1% and 0.5% of total
Hb loss, phagocytosis appears to be the predominant mechanism of removal of np- and p-RBC.
Estimates indicate that np-RBCs are cleared in approximately 10-fold excess compared to p-RBCs. An even larger
removal of np-RBCs has been described in vivax malaria anaemia. Estimates were based on two single studies both
performed on neurosyphilitic patients who underwent malaria therapy. As the share of np-RBC removal is likely to
vary between wide limits, it is important to assess the contribution of both np- and p-RBC populations to overall
RBC loss, and disclose the mechanism of such variability. As available methods do not discriminate between the
removal of np- vs p-RBCs, the purpose of this study was to set up a system allowing the simultaneous
determination of phagocytosis of p- and np-RBC in the same sample.
Methods and Results: Phagocytosis of p- and np-RBCs was quantified in the same sample using double-labelled
target cells and the human phagocytic cell-line THP-1, pre-activated by TNF and IFNγ to enhance their phagocytic
activity. Target RBCs were double-labelled with fluorescent carboxyfluorescein-succinimidyl ester (CF-SE) and the
DNA label ethidium bromide (EB). EB, a DNA label, allowed to discriminate p-RBCs that contain parasitic DNA from
the np-RBCs devoid of DNA. FACS analysis of THP-1 cells fed with double-labelled RBCs showed that p- and
np-RBCs were phagocytosed in different proportions in relation to parasitaemia.
Conclusions: The assay allowed the analysis of phagocytosis rapidly and with low subjective error, and the
differentiation between phagocytosed p- and np-RBCs in the same sample. The presented method may help to
analyse the factors or conditions that modulate the share of np-RBC removal in vitro and in vivo and lead to a
better understanding of the pathogenesis of SMA.
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Severe malaria anaemia (SMA) is a frequent cause of mor-
tality mainly in children and pregnant women [1-3]. The
most important determinant of SMA appears to be the re-
moval of non-parasitized red blood cells (np-RBCs) [4,5]
most likely by intra- and extravascular phagocytosis [1].* Correspondence: paolo.arese@unito.it
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activated human phagocytic cell line THP-1 and the
cytofluorimetric analysis of ingested p-RBCs and np-RBCs
double-labelled with the fluorescent carboxyfluorescein-
succinimidyl ester (CF-SE) and the DNA label ethidium
bromide (EB) to determine phagocytosed np- and p-RBCs,
respectively, in the same sample. The assay is very sensi-
tive, can be performed rapidly with low numbers of
p- and np-RBCs and overcomes the limitation of currently
available methods that do not differentiate between
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role of phagocytosis of p- vs np-RBCs, the presented
method may help to clarify the pathogenesis of SMA
analysing the factors or conditions that induce and
modulate the removal of np-RBC in vitro and in vivo in
both falciparum and vivax malaria.
Methods
Materials
Unless otherwise indicated all reagents were from Sigma-
Aldrich, St Louis, MO, USA. Penicillin-streptomycin was
from Invitrogen, Carlsbad, CA, USA; TNF was from Pepro-
Tech Inc, Rocky Hill, NJ, USA; IFNγ was from R&D
Systems, Minneapolis, MN, USA; bis[sulphosuccinimidyl]
suberate, sodium salt (BS3) was from Pierce Biotechnology
Inc, Rockford, IL, USA; carboxyfluorescein diacetate succi-
nimidyl ester (CFDA-SE), the non-fluorescent precursor of
CF-SE, was from Fluka, Sigma-Aldrich, Milano, Italy; anti-
D IgG (RhophylacW) were from ZLB Behring SpA, Milano,
Italy; Ficoll was from Biochrom AG, Berlin, Germany.
Cultivation of Plasmodium falciparum and stage-
dependent separation of parasites
Plasmodium falciparum parasites (Palo Alto strain,
Mycoplasma-free) were cultivated in RBCs from healthy
donors at 2% haematocrit and synchronized as described
[6]. Briefly, schizont-stage parasitized RBCs (para-
sitaemia >95%) were mixed for invasion with washed
RBCs and kept in growth medium (RPMI 1640 contain-
ing 25 mM HEPES, 30 mM glucose, 2 mM glutamine,
0.025 mM adenine, 24 mM NaHCO3, 32 mg/l gentami-
cin and 10% (vol/vol) A+ heat-inactivated human
plasma) (time 0). After 20 hr incubation in a humidified
CO2/air incubator, the ring-enriched fraction was sepa-
rated on and collected from a discontinuous 40/80/90%
vol/vol Percoll gradient containing mannitol (6% wt/vol).
After further 20 hr incubation under the same condi-
tions, the trophozoite (troph)-enriched fraction was
separated and collected as described before. Alterna-
tively, ring- and troph-stages were separated by the same
procedure from non-synchronized cultures of p-RBCs
and enriched to 60% and 90% parasitaemia, respectively.
When needed, the culture was passed through 40% (vol/
vol) Percoll containing 6% mannitol (wt/vol) to remove
residual bodies (RBs). Parasitaemia was assessed by light
microscopy after Diff-QuikW Fix staining (Medion Diagnos-
tics GmbH, Düdingen, Switzerland). Control np-RBCs were
incubated and treated in a similar way without schizont
inoculation at time 0.
Fluorescent labelling of p- and np-RBCs with CF-SE and
ethidium bromide (EB)
15 μl of packed p- or np-RBCs were suspended in 30 ml
of phosphate buffered saline-glucose (PBS-G; 150 mMNaCl, 10 mM Na2HPO4/NaH2PO4, 2 mM glucose, pH
7.4) containing 0.2 mM carboxyfluorescein diacetate
succinimidyl ester (CFDA-SE), the non fluorescent pre-
cursor of CF-SE, and incubated for 10 min at 37°C.
CFDA-SE is a non-fluorescent compound that passively
diffuses into RBCs where it is de-acetylated to the high
fluorescent CF-SE and stably retained within the RBC
upon covalent binding to intracellular amino groups [7].
The labelling reaction was stopped by adding 15 ml of
heat-inactivated foetal bovine serum (FBS) for 5 min.
Thereafter the cells were washed three times with PBS-
G and finally re-suspended in PBS-G for opsonization.
EB labelling was performed by incubating 15 μl of
packed p- or np-RBCs in 135 μl of PBS-G containing 1
mg/ml EB for 20 min at room temperature. The cells
were then washed five times with PBS-G. In double la-
belling experiments p- or np-RBCs were incubated first
with EB 1 mg/ml and then with CFDA-SE 0.2 mM as
described above. In order to minimize emission overlap
of the two fluorochromes, a minor electronic compensa-
tion was applied.
p- and np-RBC opsonization
For phagocytosis, labelled p-and np-RBC, were opsonized
with fresh homologous serum from healthy donors. RBCs
were suspended at 33% haematocrit in fresh serum,
diluted 1:1 (vol/vol) with PBS-G, incubated for 1 hr at
37°C and subsequently washed twice and resuspended in
PBS-G for the phagocytosis assay.
Phagocytosis of positive control RBCs
(a) Opsonization of np-RBCs with anti-D IgG: freshly
drawn heparinized human blood was sedimented by
centrifugation at 1,180 g for 5 min at room
temperature and mononuclear cells, platelets and
neutrophils removed by aspiration. Isolated RBCs
were washed twice with PBS-G, labelled with CF-SE
as indicated before, resuspended at 33% haematocrit
with anti-D IgG diluted 1:64 (vol/vol) with PBS-G,
and incubated for 30 min at 37°C. Negative control
RBCs were incubated in PBS-G only. After
opsonization, RBCs were washed twice and re-
suspended in PBS-G for the phagocytosis assay.
(b) Treatment of np-RBCs with zinc/BS3: washed RBCs
(see preceding section) were re-suspended at 10%
haematocrit in HEPES-saline buffer (10 mM
HEPES, 140 mM NaCl, 5 mM glucose, pH 7.4)
containing 1 mM ZnCl2 and incubated for 10 min
at room temperature. Thereafter the cross-linking
agent BS3 (200 mM stock solution in dimethyl
sulfoxide) was added to the RBC suspension to a
final concentration of 1 mM. After 10 min
incubation at room temperature, RBCs were washed
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mM ethanolamine and then twice in HEPES-saline
buffer supplemented with bovine serum-albumin
(BSA, 1% wt/vol). Washed zinc/BS3-treated RBCs
and untreated control RBCs were then labelled with
CF-SE, opsonized and resuspended in PBS-G for the
phagocytosis assay.
THP-1 cell cultivation and phagocytosis assay by flow
cytometry
Human monocytic THP-1 cells were grown in RPMI 1640
medium supplemented with 10% (vol/vol) heat-inactivated
foetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml
penicillin and 100 μg/ml streptomycin. Fresh medium was
replaced twice a week. For general maintenance, the cells
were seeded at 1 x 105 cells/ml. For phagocytosis, THP-1
cells were pre-activated by TNF (250 U/ml) and IFNγ
(50 U/ml) for 24 hr in complete RPMI-1640 medium
(RPMI 1640 medium supplemented with 10% (vol/vol)
heat-inactivated FBS, 2 mM L-glutamine, 100 U/ml
penicillin and 100 μg/ml streptomycin) in a tissue culture
polystyrene flask (Falcon, BD Biosciences, San Jose, CA,
USA). Thereafter cells were harvested and washed three
times with RPMI-1640 medium and finally re-suspended
in phagocytosis medium (RPMI 1640 medium supplemen-
ted with 10% (vol/vol) FBS), to a concentration of 3 × 105
cells/300 μl medium. Pre-activated THP-1 cells were incu-
bated for 150 min with RBCs (1.5 μl packed RBCs per
3 × 105 THP-1 cells) in 300 μl of phagocytosis medium,
into round-bottomed 5 ml polypropylene tubes (Falcon
BD Biosciences) in a humidified 5% CO2 incubator at
37°C. As a negative control, THP-1 cells were incubated in
phagocytosis medium, with untreated RBCs kept at the
same cultivation conditions. At the end of the phago-
cytosis period, the cell suspension was stratified on Ficoll
(1 ml) and subsequently centrifuged for 20 min at 914 g to
separate THP-1 cells from not-phagocytosed RBCs. The
THP-1 cells were harvested, washed once with RPMI 1640
medium, and resuspended in phagocytosis medium for
analysis of phagocytosis by flow cytometry. The fluores-
cence of THP1 was acquired on a FACSCalibur flow
cytometer (BD Biosciences, Sunnyvale, CA, USA) using
the Cell Quest software and the files obtained were ana-
lysed with the WinMDI (The Scripps Research Institute,
La Jolla, CA, USA) software. After gating the THP-1 cell
population (physical parameters analysis) excluding con-
taminating not-phagocytosed RBCs and cell debris, phago-
cytosis was quantified by fluorescence intensity of the
selected cell population. A total of at least 30,000 events
were collected per gate for each sample. First, the percent-
age of phagocytically active THP-1 cells (phTHP-1) was
assessed by counting the cells positive for CF-SE fluores-
cence. Secondly, the percentage of THP-1 cells that have
phagocytosed p-RBC (EB positive cells) was quantified.Thirdly, the number of RBCs phagocytosed per phTHP-1
was quantified by comparing the mean fluorescence inten-
sity (MFI) value of a phTHP-1 cell to the MFI value of a
labelled RBC.
Statistical analysis
Independent t-tests were performed to compare percen-
tages of phTHP-1 or numbers of RBCs phagocytosed per
phTHP-1 in different np- and p-RBCs populations.
P-values (<0.02, <0.002 and <0.001) were used to define
statistical significance and shown when appropriate.
Results
Optimization of phagocytosis assay
THP-1 pre-activation by TNF and IFNγ treatment
The human monocytic THP-1 cells were selected as
phagocytes because they express Fc and C3b receptors
[8], both essential for phagocytosis of variously damaged
or modified np-RBCs as well as p-RBCs [9]. In addition,
THP-1 cells display constant characteristics over time,
are easily cultivated and not expensive in their mainten-
ance. The intrinsically low phagocytic activity of THP-1
cells was enhanced by pre-treatment with TNF and
IFNγ, which increase phagocytic activity by upregulating
Fc- and complement receptor expression without modi-
fying phagocytic selectivity [10,11]. Pre-treatment with
cytokines was optimized at 250 U TNF and 50 U IFNγ
per ml THP-1 cell suspension (1 x 105 cells/ml) supple-
mented 24 hr before starting the phagocytosis experi-
ments. To minimize the phagocytosis-unrelated entrance
into the phagocytes of non-activated CFDA-SE leaking out
of the labelled RBCs [7] the phagocytosis time was shor-
tened to 150 min obtaining a high phagocytosis rate as
well as a negligible low non-phagocytosis-specific staining
of the phagocytes. The RBC/THP-1 ratio was optimized at
50/1, respectively (Additional file 1A-B), resulting in at
least 90% of maximal phagocytosis and low fluorescence
background.
Fluorescent labelling of np- and p-RBCs with CF-SE
Np- and p-RBCs were incubated with CFDA-SE, a non-
fluorescent compound that passively diffuses into RBCs
where it is de-acetylated to the highly fluorescent CF-SE
(carboxyfluorescein succinimidyl ester) and stably retained
within the RBC upon covalent binding to intracellular
amino groups [7]. Fluorescent RBC labelling reached a
plateau after about 10 min and was dependent on CFDA-
SE concentration and haematocrit of the RBCs suspension
(Figure 1A). Labelling conditions were experimentally
optimized at 0.2 mM CFDA-SE, 5,000 RBC/μl corre-
sponding to 0.05% haematocrit and 10 min incubation
time. Excess of extracellular protein added after incubation
stops further label entrance into RBCs. (see Methods for
details). A typical labelling experiment of np-RBC, ring-
Figure 1 Fluorescent labelling of np- and p-RBCs with CF-SE. (A) Dependence of MFI on CFDA-SE concentration (μM final) and haematocrit
in np-RBC. (black circle) 0.05%, (black square) 0.5%, (black triangle) 5% haematocrit, corresponding to 5 x 103, 5 x 104, 5 x 105 RBCs/μl, respectively.
(B) CF-SE fluorescence of np-RBCs (full grey histogram), ring-parasitized RBCs (light grey line), and troph-parasitized RBCs (dark grey line). np- and
p-RBCs were incubated as indicated in (A). (C) Absence of fluorescence quenching in np-RBCs after phagocytosis. Fluorescence of CF-SE-labelled
uningested np-RBCs (full grey histogram, MFI: 48.3 ± 1.6, N = 3) and of phTHP-1 cells fed with limiting numbers of CF-SE-labelled np-RBCs (RBCs/
THP-1 ratio = 1, full black histogram, MFI: 49.7 ± 1.1, N = 3) were very similar. For details, see Methods.
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Fluorescence intensity was substantially similar in np- and
ring-parasitized RBCs, and distinctly higher in troph-
parasitized RBCs, possibly due to an increased uptake of
the CFDA-SE or higher esterase activity in late stages of
parasite development.
Absence of fluorescence quenching after phagocytosis
Quenching of the fluorescence output of CF-SE labelled
RBCs after phagocytosis by THP-1 cells was checked. To
this end THP-1 cells were fed with limiting numbers of
anti-D IgG-opsonized np-RBCs (np-RBCs/THP-1 ratio
1:1, Figure 1C), assuming that on average each THP-1
cell had phagocytosed one np-RBC, as evidenced by the
intensity peaks shown in Figure 1C. The MFI of the
THP-1 population containing one RBC was compared
with the MFI of the labelled uningested np-RBCs. The
fluorescence intensity of the two populations was simi-
lar: 49.7 ± 1.1 (N = 3) and 48.3 ± 1.6 (N = 3) for THP-1
that have ingested one RBC and uningested RBCs, re-
spectively. Similar results were obtained with p-RBCs
(not shown), allowing the conclusion that the fluores-
cence intensity was not modified within the phagocyte.
Phagocytosis of positive control np-RBCs
The method was first checked with positive control np-
RBCs. Two RBC treatments were utilized: first, np-RBCs
were opsonized with anti-D IgG to stimulate IgG-
mediated recognition and phagocytosis via Fc-receptors
by the phagocyte. Second, np-RBCs were treated with a
combination of zinc, a band 3 clustering agent, and BS3,
a cluster-stabilizing agent (Zn/BS3). Band 3 clusters elicit
a limited activation of the complement pathway and in-
duce a predominantly complement-mediated RBC rec-
ognition and removal [12]. Both treatments induce
maximal removal of RBCs [13].
Phagocytosis of anti-D IgG opsonized np-RBCs
Phagocytosis of anti-D IgG opsonized np-RBCs was sig-
nificantly (p<0.001) increased compared to non-opsonized
np-RBCs, both as percentage of phTHP-1 cells from 3.2 ±
0.4% (non-opsonized, N = 5) to 56.9 ± 3.4% (anti-D IgG
opsonized cells, N = 5), (Figure 2A, first and second dot
plot, respectively), and as the mean number of cells phago-
cytosed per phTHP-1 from 1.0 ± 0.1(non-opsonized cells,
N = 5) to 3.6 ± 0.3 (anti-D IgG opsonized cells, N = 5)
(Figure 2B, first and second column, respectively).
Phagocytosis of Zn/BS3 treated np-RBCs
A second check with positive controls was performed with
np-RBCs treated with Zn/BS3. Their phagocytosis was also
significantly (P <0.002) increased compared to untreated
np-RBCs, both as percentage of phTHP-1 cells from 3.2 ±
0.4% (non-opsonized untreated cells, N = 5 to 25.1 ± 3.2%(Zn/BS3 treated, serum-opsonized cells, N = 5) (Figure 2A,
first and third dot plot, respectively), and as the mean num-
ber of cells phagocytosed per phTHP-1 from 1.0 ± 0.1
(non-opsonized untreated cells, N = 5) to 2.1 ± 0.3 (Zn/BS3
treated, serum opsonized cells, N = 5) (Figure 2B, first and
third column, respectively, P <0.001). Control experiments
demonstrated that serum opsonization is essential for
phagocytosis induction, as Zn/BS3 treated, non-opsonized
RBCs were not or poorly phagocytosed (Figure 2A, fourth
plot, Figure 2B, fourth column).Phagocytosis of stage-separated p- and np-RBCs
single-labelled with CF-SE
Phagocytosis experiments were performed using syn-
chronized ring- and troph-enriched fractions after
Percoll gradient separation 20 hr and 40 hr after re-
invasion, resulting in approximately 60% and >90%
rings and trophozoites respectively. p- and np-RBCs
from the same donor were stained with CF-SE, opso-
nized with human homologous serum (np-RBCs) and
fed to THP-1 cells as detailed in Materials. Phagocyt-
osis of p-RBCs increased stage-dependently either as
percentage of phTHP-1 cells or as mean number of
p-RBCs ingested per phTHP-1. phTHP-1 cells in-
creased from 6.8 ± 1.7% (np-RBCs, N = 5) to 20.8 ±
2.2% (ring, N = 5) and 50.6 ± 4.4% (troph, N = 5)
(Figure 3A, all P <0.001), while p-RBCs per THP-1 cell
increased from 1.2 ± 0.3 (np-RBCs, N = 5) to 1.8 ± 0.2
(ring, N = 5), and to 3.5 ± 0.4 (troph, N = 5)
(Figure 3B, troph vs ring and np-RBCs, P <0.001, ring
vs np-RBCs, P <0.02).Exclusion of artifacts
To exclude the presence of intact RBCs adherent to the
THP-1 surface, ice-cold distilled water was added briefly
to the cells after the phagocytosis period and immedi-
ately before FACS analysis. Physical parameters, fluores-
cence and phagocytosis data were not significantly
changed by the treatment excluding the presence of in-
tact RBCs adherent to the THP-1 surface (Figure 4A),
indicating that the Ficoll passage after phagocytosis is
sufficient to efficiently remove RBCs. Former observa-
tions with human monocytes fed with CF-SE labelled
RBCs [14] indicate that no fluorescence was associated
to membranes. Secondly, quenching activity by residual
bodies (RBs), free haemozoin expelled from the mature
schizont during merozoites release in the cultures was
examined. RBs had no influence on phagocytosis quanti-
fication as indicated by invariant results shown in
Figure 4B. Therefore, presented assay seems to be
suitable for both RBs-depleted and RBs-containing cul-
tures and for ex vivo analysis without further parasite
separation.
Figure 2 Phagocytosis by THP-1 cells of positive control np-RBCs opsonized with anti-D IgG or treated with zinc/BS3. (A) CF-SE
fluorescence vs side scatter density plots showing THP-1 cells fed with non-opsonized untreated (left plot), anti-D IgG-opsonized (second plot),
serum-opsonized, zinc/BS3-treated (third plot) and non-opsonized, zinc/BS3-treated (right plot) np-RBCs. Data are percentages of phagocytically
active THP-1 cells above the fluorescence threshold set in each experiment. One representative experiment out of five with similar results.
(B) Phagocytosis of variously treated positive control np-RBCs. Data are numbers of np-RBCs phagocytosed per phTHP-1 cell. Mean values ± SD
(N = 5) ( *P < 0.001). For details, see Methods.
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and EB
In double-labelling experiments, np- and p-RBCs were
labelled with ethidium bromide (EB), before CF-SE label-
ling. EB, a DNA intercalating agent, develops red fluor-
escence after binding to DNA. Therefore, EB was used
to distinguish DNA-free np-RBCs from p-RBCs, which
contain parasite DNA. Labelling conditions were opti-
mized at 1 mg/ml EB, 10% haematocrit (1 × 106 RBCs/μl)
and 20 min incubation time. Figure 5A shows the EB
fluorescence of a synchronized trophozoite cultures with
44% parasitaemia. The difference between np-RBCs and
troph-pRBCs reflects absence and presence of DNA,
respectively.
The aim of double staining with CF-SE and EB was to
discriminate between phagocytosis of p- and np-RBCs in
cultures containing both cell types, as only p-RBCs were
stained by EB. FACS analysis of a THP-1 population fed
with double-labelled RBCs clearly shows that p- andnp-RBCs were phagocytosed in different proportions.
Figure 5B-D shows the phagocytosis of two synchronized
cultures at trophozoite stage and approximately 8% and
44% parasitaemia. Opsonization with homologous serum
increased phTHP-1 from 9.25% and 20.9% (non-opsonized
RBCs, 8% and 44% parasitaemia, respectively) to 24.14%
and 55.51% (serum-opsonized RBCs, 8% and 44% parasit-
aemia, respectively). EB staining allowed to ascertain the
share of p- and np-RBCs ingested at different parasitaemia
values. As expected, at 44% parasitaemia the share of
ingested p-RBC increased remarkably in both opsonized
and non-opsonized samples. As shown in Figure 5C, 1.1%
(8% parasitaemia) and 5.6% (44% parasitaemia) of phTHP-
1 had phagocytosed at least one non-opsonized p-RBCs,
while 2.85% (8% parasitaemia) and 22.68% (44% parasit-
aemia) of phTHP-1 had phagocytosed at least one serum-
opsonized p-RBC. The mean number of RBCs (sum of
p- plus np-RBCs) phagocytosed per phTHP-1 was also
determined at low and high parasitaemia (Figure 5D).
Figure 3 Phagocytosis by THP-1 cells of stage-separated np- and p-RBCs single-labelled with CF-SE. (A) Fluorescence vs side scatter
density plots showing THP-1 cells fed with of serum-opsonized np-RBCs (left panel), ring-pRBCs (middle panel) and troph-pRBCs (right panel).
Data are percentages of phagocytically active THP-1 cells above the fluorescence threshold set in each experiment. One representative
experiment out of five with similar results. (B) Phagocytosis by THP-1 cells of CFDA-SE-labelled np-, ring- and troph-pRBCs. Data are numbers of
RBCs ingested per THP-1 cell. Mean values ± SD (N = 5). Phagocytosis of troph-pRBCs vs np-RBCs and vs ring-pRBCs, and phagocytosis of ring- vs
np-RBCs was significantly higher with P <0.001*, and P <0.02**, respectively. For details, see Methods.
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cytosis quantification by CF-SE fluorescence, experiments
were performed with np-RBCs stained with CF-SE only,
or with both EB and CF-SE. Results indicated no signifi-
cant difference between the two conditions (not shown).
In cultures containing both p- and np-RBCs, quantifica-
tion of phagocytosis using CF-SE labelling only did not
discriminate between phagocytosed p- or np-RBCs. By
contrast, additional DNA labelling by EB can discriminate
between p- and np-cells and allowed to simultaneously
quantify both the total number of RBCs ingested per
phTHP-1 cell as well as the ratio between ingested p- and
np-RBCs.
Discussion
This study describes a rapid, sensitive, reproducible and
accurate assay to quantify phagocytosis of p- and np-RBCs
in the same sample using CF-SE- and EB-labelled target
cells and the human phagocytic monocyte cell line THP-1.
Phagocytes were previously activated with TNF and IFNγto upregulate Fc- and complement receptors and enhance
phagocytic efficiency without loss of specificity [10,11].
Target RBCs were double-labelled with CF-SE and EB.
CF-SE is the fluorescent derivative of CFDA-SE, a non-
fluorescent lipophilic molecule that passively diffuses into
the cell where it is activated by esterase cleavage of its
acetyl groups to the brightly fluorescent derivative CF-SE.
The latter, a non-toxic molecule, is stably retained in the
cell-forming covalent conjugates to free amino groups,
emits stable and homogeneous fluorescence and does not
interfere with RBC functionality [7,15]. CF-SE does not
localize in cell membranes and does not elicit membrane
alterations that may induce phagocytic recognition of the
labelled cells. EB, a widely used DNA fluorescent label,
allows to discriminate p-RBCs that contain parasitic DNA
from the np-RBCs totally devoid of DNA.
The phagocytic efficiency of the THP-1 cells was
checked with np-RBCs modified by two treatments
known to maximally enhance phagocytosis: opsonization
with anti-D IgG to stimulate IgG-mediated phagocytosis,
Figure 4 Exclusion of artifacts caused by adherence of RBCs and residual bodies to THP-1 cells. (A) Fluorescence of THP-1 cells fed with
np-RBC-fed treated or not with water to lyse adherent intact RBCs. (B) Fluorescence of THP-1 cells fed with p-RBC in presence or absence of
residual bodies (RBs). (A, B) CF-SE fluorescence vs side scatter dot plots of THP-1 cells fed with treated or untreated RBCs are very similar
excluding artefactual adherence of RBCs or RBs to THP-1 cells. One representative experiment out of four (A) or three (B) with similar results. Data
are percentages of phagocytically active THP-1 cells counted above the fluorescence threshold set in each experiment (for details, see Methods).
Gallo et al. Malaria Journal 2012, 11:428 Page 8 of 11
http://www.malariajournal.com/content/11/1/428and RBCs treatment with zinc-BS3, that generates stable
band-3 clusters and induce a predominantly IgG/com-
plement-mediated phagocytosis [9]. Phagocytosis by acti-
vated THP-1 cells was lower compared to phagocytosis
by adherent human monocytes [9,16]. However, THP-1
cells displayed the same specificity and relative phago-
cytic activity with respect to p-RBCs as human mono-
cytes, while presenting a number of advantages, such as
independence from availability of human buffy-coats,
constant performance, low cost and easy maintenance.
Removal of large numbers of np-RBCs accompanies
the rupture of p-RBCs at schizogony, as shown by the
simultaneous presence of p-and np-RBCs in the same
phagocytic cell in peripheral blood and organ phagocytes
[17-19] and by studies on the clearance kinetics of
p- and np-RBCs [20,21]. It is generally maintained that
np-RBCs are cleared in approximately 10-fold excess
compared to elimination of p-RBC at schizogony.
However, this estimate is based on a single study [5],performed by modelling 12 neurosyphilitic patients who
underwent malaria therapy. Those authors observed a
substantial destruction of np-RBCs occurring during two
cycles of parasitaemia with peak values at 20,000-40,000
parasites per μl and estimated that an average of 8.5
np-RBCs were destroyed per rupturing schizont. An
analogous study [22] has described an even larger excess
removal of np-RBCs in vivax malaria anaemia, a fre-
quent and severe complication of vivax infection occur-
ring by largely undisclosed mechanism [23,24].
Apart from RBC lysis at schizogony, it is assumed that
phagocytosis is the predominant mechanism of removal
of np- and p-RBC. This assertion is based on a balance
study in acute SMA where a quantitative comparison
was performed between the loss of blood haemoglobin
(Hb) and increase of Hb in plasma and urine. Increase
in plasma Hb was less than 1% and excretion of Hb in
urine was less than 0.5% of total Hb loss [25]. This data
tends to exclude complement lysis [26] and is in line
Figure 5 Phagocytosis of troph-p-RBCs and np-RBCs double-labelled with EB and CF-SE. (A) EB fluorescence of a synchronized trophozoite
culture with 44% parasitaemia: troph-p-RBCs, black line, np-RBCs, full histogram. (B) CF-SE fluorescence vs EB fluorescence density plots of THP-1
cells fed with non-opsonized or serum-opsonized synchronized trophozoite cultures with 8% and 44% parasitaemia. In both upper (8%
parasitaemia) and lower (44% parasitaemia) plots, upper and lower right quadrants show phagocytically active THP-1 cells fed with troph-p-RBCs
or np-RBCs, respectively. Cells positive for CF-SE and EB were counted above the fluorescence threshold set in each experiment. One
representative experiment out of six with similar results. (C) Phagocytosis of serum-opsonized and non-opsonized troph-p- and np-RBCs by THP-1
cells in synchronized trophozoite cultures with 8% and 44% parasitaemia. Numbers on bars are percentages of phagocytically active (ph)THP-1
cells. For each phTHP-1 value the share of p- and np-RBCs in the sample is indicated. Bar data are mean values of phTHP-1 cells ± SD (N=6).
(D) Total phagocytosis of serum-opsonized and non-opsonized p- plus np-RBCs by THP-1 cells in synchronized trophozoite cultures with 8% and
44% parasitaemia. Data are numbers of p- plus np-RBCs phagocytosed per phTHP-1 cell. Bar data are mean values ± SD (N = 6). For details, see
Methods.
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senescent, variously damaged RBCs and falciparum p-
RBCs as the consequence of membrane damage and
opsonization through enhanced binding of complement
factor C3b and (anti-band 3)-IgG [9,27,28].
Most available cytofluorimetric methods (for example:
[14,29]) do not allow to discriminate the relative contribu-
tion of np- vs p-RBC removal. One exception, however, is
the method by Tippett et al [30] designed to assess phago-
cytosis by patient monocytes or by THP-1 cells of p- andnp-RBCs simultaneously labelled by EB and fluorescein
isothiocyanate (FITC). Comparison of our results with
Tippett et al’ is difficult because they used unstimulated
THP-1 cells with low phagocytic activity and FITC, a
membrane-standing molecule known to interfere with
RBC membrane transport systems and surface carbohy-
drates [31,32]. In few cases though, a comparison was pos-
sible. For example, the percentage of phagocytically active
cells was between nil and 10% in unstimulated [30], and
45% in pre-stimulated [this study] THP-1 cells when both
Gallo et al. Malaria Journal 2012, 11:428 Page 10 of 11
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RBCs. Higher phagocytic activity was also noted when
RBC suspensions with 3-8% p-RBCs were challenged by
unstimulated [30] or pre-stimulated [this study] THP-1
cells. Phagocytically active cells were approx. 2% in un-
stimulated and approx. 24% pre-stimulated THP-1 cells.
In conclusion, due to the lack of reliable quantitative
data on the relative role of phagocytosis of p- vs np-RBCs,
the method presented here may help to fill gaps particu-
larly in the pathogenesis of SMA. For example, it will be
useful to analyse the factors or conditions that modulate
the share of np-RBC removal in vitro and in vivo. It
appears that np-RBC removal may vary within broad lim-
its as documented in human SMA and in humanized
murine models and thus be an important determinant of
SMA [33,34]. The causes for this variability are unknown.
Possible factors are bystander modifications that induce
RBC membrane modifications, transfer of toxic parasite-
produced molecules in rosettes [35], malaria- or age-
related variations in phagocytosis-enhancing complement
factors [26,36] and surface IgG [37], and upregulation of
phagocytic activity of host phagocytes [20]. Phagocytosis
studies ex vivo may also help to clarify the mechanism of
malaria protection against severe anaemia observed in
correlative studies in alpha-thalassaemia patients charac-
terized by minimal alterations of RBC morphology, func-
tionality and RBC lifespan in the np-status.
Additional file
Additional file 1: Optimization of phagocytosis assay. (A)
Dependence of phagocytosis on phagocytosis time. Cell ratio: 50
np-RBCs per THP-1 cell. (B) Dependence of phagocytosis on np-RBCs/
THP-1 cell ratio. Phagocytosis time: 150 min. CF-SE-labelled, IgG
anti-D-opsonized np-RBCs were exposed at indicated cell ratios to
pre-activated THP-1 cells for various phagocytosis periods. Phagocytosis is
expressed as percentage of phagocytically-active THP-1 (phTHP-1). Mean
values ± SD (N = 4). For details, see Methods.
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